Eric Curtis - Net Worth and Insider Trading

Eric Curtis Net Worth

The estimated net worth of Eric Curtis is at least $4 dollars as of 2024-05-13. Eric Curtis is the SVP & COO of Windtree Therapeutics Inc and owns about 1 shares of Windtree Therapeutics Inc (WINT) stock worth over $4. Details can be seen in Eric Curtis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Curtis has not made any transactions after 2021-04-07 and currently still holds the listed stock(s).

Transaction Summary of Eric Curtis

To

Eric Curtis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Curtis owns 3 companies in total, including Windtree Therapeutics Inc (WINT) , LadRx Corp (LADX) , and Aegerion Pharmaceuticals Inc (AEGR) .

Click here to see the complete history of Eric Curtis’s form 4 insider trades.

Insider Ownership Summary of Eric Curtis

Ticker Comapny Transaction Date Type of Owner
WINT Windtree Therapeutics Inc 2021-04-07 SVP & COO
LADX LadRx Corp 2018-05-03 Pres. & Chief Operating Officer
AEGR Aegerion Pharmaceuticals Inc 2015-08-26 President & U.S. Commercial

Eric Curtis Latest Holdings Summary

Eric Curtis currently owns a total of 1 stock. Eric Curtis owns 1 shares of Windtree Therapeutics Inc (WINT) as of April 7, 2021, with a value of $4.

Latest Holdings of Eric Curtis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
WINT Windtree Therapeutics Inc 2021-04-07 1 4.00 4

Holding Weightings of Eric Curtis


Eric Curtis Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Curtis has made a total of 2 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 1 shares on April 7, 2021, which cost Eric Curtis around $1,993.

Insider Trading History of Eric Curtis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Curtis Trading Performance

GuruFocus tracks the stock performance after each of Eric Curtis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Curtis is -11.2%. GuruFocus also compares Eric Curtis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Curtis within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Curtis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Curtis

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.15
Relative Return to S&P 500(%) -2.64

Eric Curtis Ownership Network

Ownership Network List of Eric Curtis

No Data

Ownership Network Relation of Eric Curtis


Eric Curtis Owned Company Details

What does Windtree Therapeutics Inc do?

Who are the key executives at Windtree Therapeutics Inc?

Eric Curtis is the SVP & COO of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and SVP & CFO John P. Hamill .

Windtree Therapeutics Inc (WINT) Insider Trades Summary

Over the past 18 months, Eric Curtis made no insider transaction in Windtree Therapeutics Inc (WINT). Other recent insider transactions involving Windtree Therapeutics Inc (WINT) include a net purchase of 7,812 shares made by Craig Fraser ,

In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 434 shares were bought by its insiders, resulting in a net purchase of 434 shares.

Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Windtree Therapeutics Inc Insider Transactions

No Available Data

Eric Curtis Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Curtis. You might contact Eric Curtis via mailing address: One Main Street, Suite 800, Cambridge Ma 02142.

Discussions on Eric Curtis

No discussions yet.